Mide Büyük Kurvaturda Dev Gastrointestinal Stromal Tümör / Giant Gastrointestinal Stromal Tumor in Stomach Curvatura Major

Yıl 2017, Cilt: 39 Sayı: 2, 51 - 55, 29.03.2017

Bartu Badak

https://doi.org/10.20515/otd.302087

Öz

Öz: Gastrointestinal
stromal tümörler interstisyel  Cajal
hücrelerinden köken alan sindirim sisteminin en sık karşılaşılan mezenkimal
tümörleridir. Sindirim sisteminde en sık yerleştiği bölge mide olmakla beraber
çok az oranda da olsa gastrointestinal sistem dışındaki organlarda da
bildirilmiştir. Genellikle 4. dekad sonrası görülmekle beraber ortalama tanı
yaşı 60’tır. Semptomları genellikle karın ağrısı, şişkinlik, yutma güçlüğü,
meteorizm gibi tümöre özgü olmayan özelliklerdir. Bu sunumda mideden orijin
alan yaklaşık 20 cm’lik dev gastrointestinal stromal tümör olgusu sunulmuştur.

Anahtar
Kelimeler:  gastrointestinal stromal
tümör, dev, mide

Abstract: Gastrointestinal stromal tumours that arise from
interstitial cell of Cajal in the gastrointestinal tract are the most common
mesenchymal tumours. These tumours are usually localised in the stomach in gastrointestinal
system, although it is rarely reported to be encountered in other organs other
than gastrointestinal tract. It’s usually seen in the 4th decade, at a mean age
of 60 years. The symptoms are usually abdominal pain, bloating, dysphagia, meteorism
that are not spesific for tumour. In this presentation a giant gastrointestinal
stromal tumour that originated from stomach is performed.

Keywords: gastrointestinal
stromal tumour, giant, stomach

Anahtar Kelimeler

gastrointestinal stromal tümör, dev

Kaynakça

• 1. Mazur MT, Clark HB. Gastric stromal tumors: Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507-19.
• 2. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors Show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-69.
• 3. Miettinen M, Lasota J. Histopathology of gastrointestinal stromal tumor. J Surg Oncol 2011;104:865-873.
• 4. Yamamoto H, Kojima A, Miyakasa Y, Imamura M, Nakamura N, Yao T, Tsuneyoshi M, Oda Y. Prognostic impact of blood vessel invasion in gastrointestinal stromal tumor of the stomach. Hum Pathol. 2010 Oct;41(10):1422-30.
• 5. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumours/smooth muscle tumours (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999;23:1109-1118.
• 6. Büyükaşık O, Hasdemir OA, Dirican A, Çöl C. Gastrointestinal stromal tümörler. İnönü Üniversitesi Tıp Fakültesi Dergisi 2009;16:227-32.
• 7. Naguib SF, Zaghloul AS, El Marakby H. Gastrointestinal stromal tumors (GIST) of the stomach: retrospective experience with surgical resection at the National Cancer Institute. J Egypt Natl Canc Inst 2008;20:80-9
• 8. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33: 459-465.
• 9. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: Current diagnosis, biologic behaviour and management. Ann Surg Oncol 2000;(7):705-712.
• 10. Dizdar O, Guler N. Gastrointestinal stromal tümörler ve imatinib tedavisi. Hacettepe Tıp Dergisi 2004;35:87-91.
• 11. Miettinen M, El Rifai W, HL Sobin L, et al. Evaluation of malignancy and prognosis of gastrointestinal tumors: a review. Hum Pathol 2002;338:478-483.
• 12. Bucher P, Egger JF, Gervaz P, et al. An audit of surgical management of gastrointestinal stromal tumors (GIST). Eur J Surg Oncol 2006;32:310-4.
• 13. Demetri GD, von Mehren M, Blanke CD, et al. Efficiacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;(347):472-480.